Andere talen Cerevel Therapeutics Holdings, Inc.

Aandelen

CERE

US15678U1280

Geschatte realtime Cboe BZX Andere beurzen 20:04:11 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
42,1 ^USD	-0,08%		+0,63%	-0,67%

18/04	Cerevel Therapeutics' medicijn tegen de ziekte van Parkinson behaalt hoofddoel in laat stadium onderzoek	RE
18/04	Cerevel Therapeutics kondigt positieve resultaten aan voor tavapadon in Fase 3 aanvullend onderzoek voor mensen die leven met de ziekte van Parkinson	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease	15:23
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	18/04
Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study	18/04
Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study	18/04
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease	18/04
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson?s Disease	18/04
Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation	25/03
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing	04/03
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Sector Update: Health Care Stocks Gain Late Afternoon	22/02
AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions	22/02
Phew! The party continues!	22/02
AbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reports	22/02
North American Morning Briefing : Stock Futures -2-	21/02
AbbVie CEO to Retire; COO Robert Michael Named Successor	20/02
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13/02
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance	12/02
AbbVie 4Q Sales Lower as Himura Revenue Sinks	02/02
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals	02/02
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer	22/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cerevel Therapeutics Holdings, Inc.

Aandelen

CERE

US15678U1280

Andere talen

Filters